baber/WOPTO huggingface dataset:
Patent NZ-556758-A (NZ)
Title: Invoice financing
Inventor: KERDACHI NEVILLE WINSTON JOSEPH
IPC: G06Q30/00
Filed: 2005-10-25
Abstract: An electronic invoice financing system (10) includes debtor approval manager (16); a supplier invoice transmitter (12) configured to transmit details of a supplier invoice electronically from a supplier to the debtor approval manager (16) operable by, or operable to assist, at least one financial institution which finances invoices issued by the supplier and a debtor accounts payable transmitter(14) which is programmable electronically to transmit details of a supplier invoice approved for payment, to the debtor approval manager. The debtor approval manager which includes, or which has access to, a database of approved debtors and which is configured to receive invoice details from the supplier invoice transmitter and from the debtor accounts payable transmitter. The debtor approval manager is programmed to compare or match invoice details received from the supplier invoice transmitter and from the debtor accounts payable transmitter and selectively to indicate the status of an invoice for which details were received from the supplier invoice transmitter as validated or verified, or non-validated, depending on whether or not corresponding invoice details were also received from the debtor accounts payable transmitter and whether or not a debtor is an approved debtor, and then either (I) to transmit the invoice status information to a financial institution so that the financial institution can then consider providing credit to the supplier, up to a predetermined percentage of a value of the validated supplier invoice, or (II) to provide credit on behalf of the financial institution to the supplier, up to the predetermined percentage of the value of the validated supplier invoice.
Patent NZ-561168-A (NZ)
Title: Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity
Inventor: GEBBINK MARTIN FRANS BEN GERARD
IPC: A61K38/00
Filed: 2003-07-08
Abstract: Disclosed is the use of a compound capable of binding to a crossbeta structure for the preparation of a medicament for diminishing unfolded proteins having adopted a partially structured conformation, involved in a conformational disease, wherein said compound is an antibody or comprises a finger domain, wherein said finger domain is derived from fibronectin, FXll or HGFa, and wherein said disease is a disease characterized by amyloid, atherosclerosis, diabetes, bleeding, thrombosis, cancer, sepsis, Multiple Sclerosis, auto-immune diseases, rheumatoid arthritis, disease associated with loss of memory or Parkinson's disease and/or epilepsy.
Patent NZ-561787-A (NZ)
Title: Improvements relating to graphical user interfaces
Inventor: STEIN MICHAEL LEWIS
IPC: G06F9/44
Filed: 2004-03-24
Abstract: A graphical user interface (GUI) for interacting with a user during a workflow process is disclosed. The GUI comprises searching means arranged to search an externally accessible knowledge base. The searching means comprises conversion means arranged to convert a user-selected information topic from the GUI into a predetermined classification code representing that topic; and transmission means arranged to transmit the classification code within an information request over a communications network to the knowledge base to access information contained therein corresponding to the classification code. The predetermined classification code is readily understandable by the knowledge base. The searching means is arranged to: (a) receive a response to the information request the response comprising the accessed information; and (b) display the accessed information to the user.
Patent NZ-562962-A (NZ)
Title: Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
Inventor: BACH FRITZ H
IPC: C12N5/074
Filed: 2002-06-21
Abstract: Disclosed is the use of carbon monoxide in the manufacture of a pharmaceutical composition for the treatment of chronic rejection in a patient undergoing or about to undergo chronic rejection of a transplanted organ or tissue. (62) (62) Divided Out of 530671
Patent NZ-563383-A (NZ)
Title: A razor
Inventor: BRYAN RICHARD WAYNE
IPC: A45D27/00
Filed: 2007-11-13
Abstract: A manual shaving apparatus comprising plurality of blade stacks. Each blade stack comprises a plurality of identical blades. Each blade includes at least two cutting edges. The blades in each stack are orientated to be in register with each other. Each blade in a stack is arranged to allow rotation about a common axis and to present a cutting edge of each blade in each stack in a common plane.
Patent NZ-571328-A (NZ)
Title: Device for industrial production of biocatalysts in the form of enzymes or microorganisms immobilized in polyvinyl alcohol gel
Inventor: STLOUKAL RADEK
IPC: B01J2/00
Filed: 2007-03-06
Abstract: Disclosed is an industrial production device when used in a method for the industrial production of a biocatalyst with biologically active material in the form of enzymes or microorganisms which are immobilised on a polyvinyl alcohol gel, and wherein the biocatlyst is to be shaped into belts with a surface to volume geometric ratio of greater than 7 mm-1, said device comprising: a casting mechanism (17) mounted in front of a drying channel (2), through which a continuous conveyor belt (1) runs, and wherein the device is equipped with at least one casting head (17) with two rows of casting needle injectors connected to a pressure tempered tank (15) and a compressor (16), the conveyor belt (1) and a drying system - the source (4) of a drying air, which is blown by means of ventilator into an air distribution system (6) with incorporated heating elements (5), which runs into the upper drying channel (2), and further the lower final drying channel (3) and a re-swelling tank (7), between which a wiping and collecting device for collecting re-swelled salts (9) is mounted, designed on the basis of mechanical wiping and high-pressure rinse, which is connected to a pipeline with integrated high-pressure pump (10) and low-pressure pump (11) running into a collecting reservoir (8) with cooling and further a rinse box (13), a continuous conveyor belt (1) and a final cleaning by jets connected to a low pressure pump (14), which is connected to a rinse tank (12) by a pipeline.
Patent NZ-575674-A (NZ)
Title: Anti-VEGF antibodies
Inventor: FUH GERMAINE
IPC: C12N15/62
Filed: 2004-07-30
Abstract: Provided is an anti-VEGF antibody, or Fab fragment thereof, comprising a heavy chain variable domain comprising a CDR H1, CDR H2, and CDR H3, and a light chain variable domain comprising a CDR L1, CDR L2, and CDR L3 wherein: (a) CDR H1 comprises the contiguous amino acid sequence DYWIH; (b) CDR H2 comprises the contiguous amino acid sequence GVTPAGGYTYYADSVKG or GVTPAGGYTAYADSVKG; CDRH3 comprises the contiguous amino acid sequence FVFFLPYAMDY; (d) CDR L1 comprises the contiguous amino acid sequence RASQDVSTAVA; (e) CDR L2 comprises the contiguous amino acid sequence SASFLYS; and (f) CDR L3 comprises the contiguous amino acid sequence KQGFANPFT. Further provided are corresponding isolated nucleic acids. The antibodies can be used for treating angiogenesis associated disorders or inflammatory and immune disorders. (62) Divided Out of 545135
Patent NZ-577920-A (NZ)
Title: A rotor blade for a wind turbine with a winglet that is twisted in its central plane by aprox 5 degrees
Inventor: WOBBEN ALOYS
IPC: F03D1/00
Filed: 2005-02-10
Abstract: A rotor blade for a wind turbine is disclosed. The rotor blade tip region has a tip or a tip end plate which rises out of the plane of the rotor blade in the manner of a winglet. The tip or tip end plate is turned about a thread axis in its central plane by about 4 to 8 degrees. The tip in this configuration has no contribution towards lift as the twist has a neutral afflux angle.
Patent NZ-578472-A (NZ)
Title: Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
Inventor: FERRARA NAPOLEONE
IPC: A61K38/17
Filed: 2007-12-18
Abstract: Disclosed is the use of an anti-VEGF antibody, or antigen binding fragment thereof, that blocks VEGF binding to VEGFR1 and VEGFR2, in the manufacture of a medicament for preventing occurrence or recurrence of a benign, pre-cancerous, or non-metastatic cancer in a subject, wherein the subject has a family history of cancer, polyps, or an inherited cancer syndrome, and wherein the subject does not have cancer.
Patent NZ-579612-A (NZ)
Title: Brush, for untangling hair, with flexible plastic bristles of alternating lines of long and short length
Inventor: PULFREY SHAUN
IPC: A46B9/02
Filed: 2008-02-20
Abstract: A hair care device is for use in untangling hair has a body portion (10a, 10b) and projecting therefrom a plurality of substantially parallel flexible bristles (12a, 12b) made of soft plastics material, said bristles being arranged such that over at least a part of the area of said bristles, some of said bristles are of shorter length (12b) such that the bristles and the shorter length bristles are interspersed over said at least part of the area of bristles.
Patent NZ-579897-A (NZ)
Title: Closure system for casement window with cranking assembly and corner gear to connect axles
Inventor: FORRESTAL DAVID PETER
IPC: E05F11/08
Filed: 2009-09-24
Abstract: A closure system is disclosed for a casement window having a cranking assembly mounted to a first side of a frame of the window for use by an operator to drive a first axle, a window opening assembly mountable on a second hinged side of the window and driven by a second axle, and a corner gear transmission assembly to interconnect the first axle and the second axle.
Patent NZ-582921-A (NZ)
Title: Multilayer film having passive and active oxygen barrier layers
Inventor: BECKWITH SCOTT
IPC: B29C48/21
Filed: 2008-07-23
Abstract: Disclosed is a multilayer active oxygen barrier film comprising a multilayer oxygen barrier component comprising at least one of i) an active oxygen barrier layer that is disposed between two opposing passive oxygen barrier layers, or ii) a passive oxygen barrier layer that is disposed between two opposing active oxygen barrier layers, wherein the active oxygen barrier layer comprises an oxygen scavenging composition that is a blend of: (A) a thermoplastic resin having carbon-carbon double bonds substantially in its main chain; (B) a transition metal salt; and (C) an oxygen barrier polymer selected from the group consisting of ethylene-vinyl alcohol copolymer (EVOH), polyvinyl alcohol, polyvinyl chloride, polyacrylonitrile, and combinations thereof, wherein the passive oxygen barrier layer is selected from the group consisting of ethylene vinyl alcohol, polyvinyl alcohol, and copolymers and combination thereof, and wherein the multilayer oxygen barrier component is disposed between an outer sealant layer and an outer abuse layer, and wherein the film has an oxygen scavenging rate that is at least about 0.01 cc oxygen per day per gram of the oxygen scavenging composition blend.
Patent NZ-587315-A (NZ)
Title: Coalescing agents having low volatile organic content
Inventor: ZHOU LICHANG
IPC: C09D7/45
Filed: 2009-01-30
Abstract: The disclosure relates to the field of coalescing agents and, in particular, coalescing agents utilized in coating compositions, and related methods for use and preparation thereof. Disclosed herein is a low VOC coalescent agent composition comprising at least two of the dibasic esters depicted herein, which are selected from the dibasic esters of formulae (III), (IV) and (V), wherein R1 and R2 individually comprise a C4-C8 alkyl group. Further disclosed is a latex coating composition comprising at least one latex polymer; water; and said low VOC coalescent agent.
Patent NZ-588408-A (NZ)
Title: Method of isolating proteins using polyethylene glycol and zinc
Inventor: GRONKE ROBERT S
IPC: G01N33/50
Filed: 2009-04-16
Abstract: A method for purifying a protein from a composition containing an impurity that comprises the steps: (a) Adding polyethylene glycol to the composition; (b) Adding zinc to the composition; (c) Allowing the protein to form a precipitate following any order of steps (a) and (b); (d) Collecting the precipitated protein. The polyethylene glycol and zinc are the only precipitating agents used in the method. The method can be used to purify a recombinant antibody.
Patent NZ-590674-A (NZ)
Title: Sustained Release Oral Tablet Formulations and Associated Methods
Inventor: MELAKU TESHOME
IPC: A61K9/24
Filed: 2007-07-19
Abstract: Disclosed is a solid oral dosage pharmaceutical tablet comprising a first layer including at least one opioid, the first layer disposed between two adjacent controlled release layers, at least one of said adjacent controlled release layers including at least one non-opioid analgesic, wherein: a. the two adjacent controlled release layers cover substantially the entire first layer around a peripheral edge thereof, and/or b. a portion of the two adjacent controlled release layers are joined into a single layer, wherein the non-opioid analgesic is selected from the group consisting of acetaminophen, aspirin, acetylsalicylic acid, methyl salicylate, diflunisal, ibuprofen, diclofenac, naproxen, Benoxaprofen, flurbiprofen, fenoprofen, flubufen, ketoprofen, indoprofen, piroprofen, carprofen, oxaprozin, pramoprofen, muroprofen, trioxaprofen, suprofen, aminoprofen, ketorolac, tiaprofenic acid, fluprofen, bucloxic acid, indomethacin, sulindac, tolmetin, zomepirac, tiopinac, zidometacin, acemetacin, fentiazac, clidanac, oxpinac, mtfenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, tolfenamic acid, diflurisal, flufenisal, piroxicam, sudoxicam, isoxicama, celecoxib (SC-58635), DUP-697, flosulide (COP-28238), me1oxicam, 6-methoxy-2-naphthylacetic acid (6-MNA), rofecoxib (MK-966), nabumetone, nimesulide, NS-398, SC-5766, SC-58215, T-614, amantadine (l-aminoadamantine), memantine (3,5 dimethylaminoadamantone), valdecoxib, dextrorphan, dextromethorphan, ketamine, eliprodil, ifenprodil, dizocilpine, remacemide, iamotrigine, riluzole, aptiganel, phencyclidine, flupirtine, celfotel, felbamate, spermine, spermidine, levemopamil, APV, muscle relaxants, avermectins, barbiturates, bicucullines, benzodiazepines, baclofen, cannibinoids, carbamazepines, cyclopryrrolone derivatives and zopiclone, ethanol, gabapentin, gabazine, gamma-hydroxybutyrate (ORB), imidazopyridines such as zaleplon and zolpidem, muscimol, phenyloin, picrotoxin, progabide, propofol, thujone, valproate, and pharmaceutically acceptable salts, esters, metabolic precursors, or combinations thereof.
Patent NZ-593345-A (NZ)
Title: Antimicrobial composition comprising a quinolone carboxylic acid derivative and a cyclodextrin
Inventor: LI DANPING
IPC: A01N43/42
Filed: 2009-11-12
Abstract: 593345 The present disclosure relates to antimicrobial compositions and more specifically compositions of a quinolone carboxylic acid derivative (delafloxacin) with a cyclodextrin. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
Patent NZ-594252-A (NZ)
Title: Method for preparing cholyl-L-lysine from N-e-CBZ-cholyl-L-lysine
Inventor: ROBERTS TOMOS HUW
IPC: C07J41/00
Filed: 2010-02-10
Abstract: Disclosed is a process for the preparation of cholyl-L-Iysine (6-amino-2-((4R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)hexanoic acid) comprising the steps of: (a) reacting N-[epsilon]-CBZ-cholyl-L-Iysine with a hydrogen source in the presence of a catalyst in a solvent comprising one or more alkanols; (b) removing the catalyst; (c) optionally diluting the resulting reaction mixture with water and optionally adjusting the pH of the resultant reaction mixture to a pH less than or equal to about 4; (d) removing the bulk of the alkanol whilst ensuring that the alkanol content of the resultant mixture is maintained above about 3% w/w of the remaining mixture; (e) extracting the resultant mixture from step (d) with an organic solvent; (f) adjusting the pH of the aqueous layer to a pH of about 4.5 or greater to precipitate cholyl-L-Iysine; (g) isolate the precipitate.
Patent NZ-595299-A (NZ)
Title: Method and apparatus for sequestering carbon dioxide from a spent gas
Inventor: METIUS GARY EDWARD
IPC: C01B32/50
Filed: 2010-04-19
Abstract: A method and apparatus for sequestering carbon dioxide from a waste gas and reusing the waste gas as a recycled gas without emissions concerns. Gas source is divided into a process gas and a waste gas. Process gas is mixed with a hydrocarbon and fed into a reformer for forming a reducing gas. At least a portion of the waste gas is fed into a carbon dioxide scrubber, forming a carbon dioxide lean gas that is mixed with the reducing gas. Optionally, the gas source and the reducing gas are associated with a direct reduction process for converting iron oxide to metallic iron.
Patent NZ-597265-A (NZ)
Title: A gas filter apparatus comprising a rotary back-flushing gas pulse distributor for self-cleaning
Inventor: CHRISTIANSSON KARL AUGUST
IPC: B01D46/04
Filed: 2010-06-22
Abstract: 597265 A fabric filter is disclosed including a clean air plenum (13) and a dirty gas side (12) separated by a cell plate (14) which includes concentric rings of holes (15) providing gas communication between the two sections. The holes connect to respective filter media bags (16) for collecting contamination held in suspension in the gas being filtered. In order to clean the filter bags there is provided a back flushing gas pulse generator (18) which includes a main diaphragm valve in direct communication with a hollow rotatable shaft which leads to a gas pulse distributor having arms which sweep across the clean air plenum side of the cell plate. A supply throttle is located in a supply line to the gas pulse generator such that reverse flow is restricted when a gas pulse generator associated with an adjacent fabric filter if operated.
Patent NZ-597647-A (NZ)
Title: Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
Inventor: MITCHELL IAN S
IPC: A61K31/496
Filed: 2007-07-05
Abstract: Abstract 597647 The present disclosure provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula (I). Also provided are methods of using the compounds of this disclosure as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. The compounds of the disclosure include: (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5Hcyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one, (R)-3-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-2-(isopropyl(methyl)amino)propan-1-one, (R)-3-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-2-(piperidin-4-ylamino)propan-1-one, (R)-4-(3-(1H-imidazol-1-yl)propylamino)-2-(4-bromophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5Hcyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)butan-1-one, (R)-2-(4-bromophenyl)-4-(dimethylamino)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5Hcyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)butan-1-one and 2-(4-chlorophenyl)-1-(4-((5R)-7-hydroxy-5,7-dimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one.
Patent NZ-598127-A (NZ)
Title: Cancer metastasis inhibitor
Inventor: MAEDA SHIN
IPC: A61K39/395
Filed: 2010-07-30
Abstract: 598127 Disclosed is the use of an anti-IL-6 receptor antibody in the manufacture of a medicament for suppressing metastasis of lung cancer to the liver, provided that the medicament is not administered simultaneously, separately or sequentially with a proteasome inhibitor.
Patent NZ-601319-A (NZ)
Title: Antiviral combinations involving (4r,12as)-n-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2h-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
Inventor: UNDERWOOD MARK RICHARD
IPC: A01N43/00
Filed: 2011-01-24
Abstract: Disclosed are combinations comprising (4R, 12aS)-N-[2,4-flurophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide (also known as dolutegravir and GSK1349572), abacavir and lamivudine. Also disclosed is the use of the combination in the manufacture of a medicament for the treatment of the HIV virus.
Patent NZ-603564-A (NZ)
Title: Combinations including cry34ab/35ab and cry3ba proteins to prevent development of resistance in corn rootworms (diabrotica spp.)
Inventor: MEADE THOMAS
IPC: A01N37/18
Filed: 2011-04-22
Abstract: Disclosed is a transgenic plant that produces a Cry34 insecticidal protein, a Cry35 insecticidal protein and a Cry3Ba insecticidal protein, the plant can further produce Cry6A insecticidal protein. Also discloses the seeds, fields and methods of producing said transgenic plant.
Patent NZ-626407-A (NZ)
Title: Process for producing differentiated cellulose fibers comprising an enzymatic treatment in association with an acid step
Inventor: MAMBRIM FILHO OTAVIO
IPC: D21C9/00
Filed: 2009-10-16
Abstract: Disclosed is a process for producing cellulose fibers, wherein the process comprises the association of at least one enzymatic treatment, in which the pH of the medium is higher than 5.5, with at least one acid step, in which the pH of the medium is lower than 4.5 wherein the acid step is applied sequentially before or after the enzymatic treatment during the process for obtaining cellulose fibers and wherein in the enzymatic treatment hydrolytic enzymes selected from the group consisting of cellulases, xylanases and mixtures thereof is used.
Patent NZ-628919-A (NZ)
Title: Method, apparatus and transducer for use in determining the cut of a mechanical lock
Inventor: NEDWELL JEREMY
IPC: E05B19/20
Filed: 2013-02-15
Abstract: In order to determine the particular cut possessed by a tumbler of a mechanical lock, the tumbler is stimulated with mechanical energy. The vibrational response of the tumbler is detected, and the detected response is used in determining which cut of the plurality of possible cuts the tumbler possesses. The cut of a lock tumbler is defined by its shape and/or size. For example, in the case of a pin-tumbler lock, the cut of a pin is defined by its length. Different cuts of tumbler will therefore exhibit different vibrational responses to stimulation by mechanical energy, and these different vibrational responses can be used to determine which cut the tumbler possesses, for example by comparing with the vibrational responses of real or modelled tumblers with known cuts. The response may be detected while the tumbler is being stimulated, and the responses to different frequencies of stimulation may be detected and processed.